Condensed Statement of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
Revenue
Costs and expenses:
Research and development	362	234
General and administrative expenses	1,979	1,466
Depreciation and amortization	4	2
Loss on sale of fixed assets		10
Total costs and expenses	2,345	1,712
Operating loss	(2,345)	(1,712)
Other non-operating income (expense):
Other income:	10	64
Change in fair value of derivative instruments
Related party	(1,281)	273
Other	15	67
Interest expense related party	(1,441)	(1,116)
Total other non-operating income (expense)	(2,697)	(712)
Loss before income tax benefit	(5,042)	(2,424)
Income tax benefit	1,684
Net loss	$ (3,358)	$ (2,424)
Net loss per share, basic and diluted	$ (0.06)	$ (0.04)
Weighted average shares outstanding, basic and diluted	60,687,478	60,687,478